ストックスクリーナーアプリを入手
13.41
0.15%
-0.02
アフターアワーズ：
13.40
-0.010
-0.07%
前日終値:
$13.43
開ける：
$13.44
24時間の取引高:
2.63M
Relative Volume:
0.31
時価総額：
$3.52B
収益：
$6.16B
当期純損益:
$246.00M
株価収益率:
14.29
EPS:
0.9387
ネットキャッシュフロー:
$708.00M
1週間 パフォーマンス:
-0.07%
1か月 パフォーマンス:
+19.09%
6か月 パフォーマンス:
+73.26%
1年 パフォーマンス:
+54.32%
1日の値動き範囲:
$13.39
$13.44
1週間の範囲:
$13.39
$13.48
52週間の値動き範囲:
$5.69
$13.48
Organon Co Stock (OGN) Company Profile
Compare OGN vs LLY, JNJ, ABBV, MRK, AZN
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
13.41 | 3.53B | 6.16B | 246.00M | 708.00M | 0.9387 |
LLY
Lilly Eli Co
|
1,064.74 | 949.70B | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
230.18 | 564.11B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
213.12 | 381.10B | 62.82B | 3.60B | 19.98B | 2.0274 |
MRK
Merck Co Inc
|
119.72 | 302.33B | 65.51B | 8.93B | 14.12B | 3.5532 |
AZN
Astrazeneca Plc
|
187.19 | 290.06B | 60.48B | 10.40B | 8.05B | 3.3297 |
Organon Co Stock (OGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-09 | 開始されました | Barclays | Underweight |
| 2025-10-27 | ダウングレード | Piper Sandler | Overweight → Underweight |
| 2025-05-02 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2024-09-06 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2023-11-03 | ダウングレード | Goldman | Buy → Neutral |
| 2023-09-21 | 開始されました | Barclays | Overweight |
| 2023-03-16 | 開始されました | Raymond James | Outperform |
| 2022-10-14 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-09-06 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-08-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-04-27 | 開始されました | Goldman | Buy |
| 2022-04-06 | 再開されました | Morgan Stanley | Equal-Weight |
| 2021-10-07 | 開始されました | Piper Sandler | Neutral |
| 2021-09-01 | 開始されました | BofA Securities | Buy |
| 2021-07-22 | 開始されました | Citigroup | Buy |
| 2021-06-15 | 開始されました | JP Morgan | Neutral |
| 2021-06-11 | 開始されました | Morgan Stanley | Equal-Weight |
| 2021-06-10 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Organon Co (OGN) 最新ニュース
(OGN) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Sun Pharma to Acquire Organon for $11.75 Billion in All-Cash Transaction - The Healthcare Technology Report.
Sun Pharma, Coforge: Indian businesses go shopping abroad as growth slows at home - BBC
Organon & Co is the best performing healthcare stock in April - MSN
OGNOrganon & Co Stock Price and Quote - Finviz
Sun Pharma sees steady FY27 growth, progresses $11.75 bn Organon integration deal - The Economic Times
OGN Stock Chart | ORGANON & CO (NYSE:OGN) - ChartMill
Hanmi Pharmaceutical Faz Parceria com a Organon para Exportação de Terapias de Combinação para o Sudeste Asiático - GlobeNewswire Inc.
Organon to supply Hanmi’s 3 combo drugs in Malaysia, Philippines - koreabiomed.com
What Sparked Organon's Recent Stock Surge - Kavout
Hanmi Pharmaceutical Partners with Organon to Export Combination Therapies to Southeast Asia - Macau Business
OGN Stock Price, Quote & Chart | ORGANON & CO (NYSE:OGN) - ChartMill
Organon (OGN) price target increased by 25.58% to 11.02 - MSN
10 Incredible Facts About Sun Pharma’s Historic $11.75 Billion Organon Acquisition - AOL.com
Organon & Co. (OGN) Leads Mid-Cap Stocks with Low Forward P/E Ra - GuruFocus
Sun Pharma’s $11.75 billion Organon bet marks India Inc’s biggest pharma buy - MSN
Organon & Co stock hits 52-week high at $13.44 By Investing.com - Investing.com Nigeria
Organon & Co. (OGN) is attracting investor attention: Here is what you should know - MSN
Organon & Co stock hits 52-week high at $13.44 - Investing.com
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
1OGN.MI Stock Price, Quote & Chart | ORGANON & CO (BIT:1OGN) - ChartMill
Organon to Present New Research on Access and Value at ISPOR 2026 - BioSpace
Sun Pharma's $11.75-billion Organon deal: What it means for Indian pharma M&As - MSN
Organon jumps 15% as Sun Pharma agrees $11.8bn buyout - MSN
Why is OGN stock rising in pre-market today? - MSN
Sun Pharma to buy Organon in $11.75B deal, expanding global reach - MSN
Organon & Co. (NYSE:OGN) Receives Average Rating of "Reduce" from Brokerages - MarketBeat
VIRGINIA RETIREMENT SYSTEMS ET Al Raises Stock Holdings in Organon & Co. $OGN - MarketBeat
BT explainer: Why Sun Pharma's $11.75-bn Organon deal is priced below past pharma acquisitions - MSN
Organon & Co(OGN) Stock Options Chain | Quotes & News - Moomoo
Sun Pharma to acquire Organon for $11.75bn - MSN
Sun Pharma to acquire Organon in $11.75 billion all-cash deal - MSN
Sun Pharmaceutical Industries jumps 7% on $11.75 bn Organon & Co. buyout - MSN
Notable healthcare headlines for the week: J&J, Abbott and Organon in focus - MSN
Liquidity Mapping Around (OGN) Price Events - Stock Traders Daily
Earnings snapshot: Organon & Co. misses bottom-line estimates; initiates FY26 outlook - MSN
India's Sun Pharma to buy Organon in $11.75 billion all-cash deal - MSN
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisition - MSN
Organon & Co (OGN) Stock Price Quote Today & Current Price Chart - Capital.com
Sun Pharma secures bridge loan for $12 billion Organon purchase - MSN
India’s Sun Pharma plots $12 billion Organon buyout for global reach - MSN
Organon Co (OGN) 財務データ
収益
当期純利益
現金流量
EPS
0.19%
0.09%
大文字化:
|
ボリューム (24 時間):